Carbidopa / Levodopa Orion 25 mg / 100 mg tablets
- Licence status
- Withdrawn: 30/09/2025
- Active substances
- Carbidopa monohydrate, Levodopa
- Dosage Form
- Tablet
- Licence number
- PA1327/021/002
- Licence holder
- Orion Corporation
Product documents
- Package Leaflet
- Summary of Product Characteristics
- Public Assessment Report
Licence information
- ATC code
- N04BA02 levodopa and decarboxylase inhibitor
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 16/12/2022